Defining the susceptibility of colorectal cancers to BH3-mimetic compounds.

MLA

Luo, Ming-Jie, et al. “Defining the Susceptibility of Colorectal Cancers to BH3-Mimetic Compounds.” Cell Death & Disease, vol. 11, no. 9, Sept. 2020, p. 735. EBSCOhost, https://doi.org/10.1038/s41419-020-02815-0.

APA

Luo, M.-J., Palmieri, M., Riffkin, C. D., Sakthianandeswaren, A., Djajawi, T. M., Hirokawa, Y., Shuttleworth, V., Segal, D. H., White, C. A., Nhu, D., Lessene, G., Lee, M., Gibbs, P., Huang, D. C. S., Sieber, O. M., & Gong, J.-N. (2020). Defining the susceptibility of colorectal cancers to BH3-mimetic compounds. Cell Death & Disease, 11(9), 735. https://doi.org/10.1038/s41419-020-02815-0

Chicago

Luo, Ming-Jie, Michelle Palmieri, Chris D Riffkin, Anuratha Sakthianandeswaren, Tirta Mario Djajawi, Yumiko Hirokawa, Victoria Shuttleworth, et al. 2020. “Defining the Susceptibility of Colorectal Cancers to BH3-Mimetic Compounds.” Cell Death & Disease 11 (9): 735. doi:10.1038/s41419-020-02815-0.